Med BioGene Inc. announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced net loss was USD 19,708 compared to USD 7,792 a year ago. For the nine months, net loss was USD 60,196 compared to USD 45,416 a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.